Plasma Fractionation Market Share

Statistics for the 2023 & 2024 Plasma Fractionation market share, created by Mordor Intelligence™ Industry Reports. Plasma Fractionation share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Life Science Research Technologies Research Emerging Technology Research Plasma Fractionation Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Plasma Fractionation Industry

The plasma fractionation market is moderately competitive and consists of several major players. Companies like Bio Products Laboratory, China Biologic Products, CSL Behring, Grifols S.A., Takeda Pharmaceutical Company Ltd, Kedrion S.p.A, Octapharma, Shanghai RAAS Blood Products, among others, hold a substantial market share in the market. These significant companies in the market are engaging in partnerships, mergers, and acquisitions, aiming to strengthen their product portfolios and manufacturing capacities and provide competitive differentiation.

Plasma Fractionation Market Leaders

  1. CSL Behring

  2. Grifols S.A

  3. Octapharma

  4. Kedrion S.p.A

  5. Bio Products Laboratory

*Disclaimer: Major Players sorted in no particular order

Plasma Fractionation Market Concentration

Plasma Fractionation Market Report Snapshots

Plasma Fractionation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)